Joudaki, Hanane
Aria, Negar
Moravej, Roya
Rezaei Yazdi, Mohamadreza
Emami-Karvani, Zarrindokht
Hamblin, Michael R. http://orcid.org/0000-0001-6431-4605
Funding for this research was provided by:
University of Johannesburg
Article History
Received: 12 January 2023
Accepted: 2 September 2023
First Online: 17 October 2023
Declarations
:
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc., Cleveland, OH; Hologenix Inc. Santa Monica, CA; Vielight, Toronto, Canada; JOOVV Inc., Minneapolis-St. Paul MN; Sunlighten, Kansas City, MO; PBM Healing International, Hong Kong. POLYTONE LASER INC. Montreal, Canada; Guangzhou Heavy Rain Culture Communication Co., Ltd., Guangzhou, China. Consulting; USHIO Corp, Japan; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany; Klox Asia, Guangzhou, China. Stockholding: Niraxx Light Therapeutics, Inc., Irvine CA; JelikaLite Corp, New York NY; Danvantar Biophotonics Oy, Helsinki, Finland. The other authors declare no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.